Richard Ian Griffiths - 22 Jun 2025 Form 4 Insider Report for Silence Therapeutics plc (SLN)

Role
10%+ Owner
Signature
/s/ Richard Ian Griffiths
Issuer symbol
SLN
Transactions as of
22 Jun 2025
Net transactions value
$0
Form type
4
Filing time
25 Jun 2025, 08:59:53 UTC
Previous filing
20 Jun 2025
Next filing
30 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Griffiths Richard Ian 10%+ Owner FLOOR 1 LIBERATION STATION, ESPLANADE, ST HELIER, JERSEY /s/ Richard Ian Griffiths 25 Jun 2025 0001846370

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLN American Depositary Shares Purchase +20,977 +0.18% 11,452,805 22 Jun 2025 Ordinary Shares 62,931 $5.84 Direct F1
transaction SLN American Depositary Shares Purchase +35,005 +0.31% 11,487,810 23 Jun 2025 Ordinary Shares 105,015 $5.88 Direct F1
transaction SLN American Depositary Shares Purchase +26,624 +0.23% 11,514,434 24 Jun 2025 Ordinary Shares 79,872 $6.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.